News Conference News EuroPCR 2019 TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement Shelley Wood May 23, 2019
News Conference News EuroPCR 2019 Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats Michael O'Riordan May 22, 2019
News Industry News BioTrace Medical’s Tempo Lead Obtains CE Mark for Safe and Secure Temporary Intracardiac Pacing May 08, 2019
News Daily News Public Comments Largely Supportive of CMS Plan for TAVR, With Some Suggested Tweaks Todd Neale May 01, 2019
News Daily News Women Have Higher Risk of TAVR-Related Pericardial Complications Todd Neale April 26, 2019
News Daily News Continuing Anticoagulation During TAVR: New Data Offer a Glimpse of What Works Shelley Wood April 16, 2019
News Daily News Latest Observational Data Support TAVR Durability Through 7 Years Caitlin E. Cox April 12, 2019
News Conference News ACC 2019 My Takeaways From ACC 2019: Breaking With Embargoes? Despite the Drama, Embargoes Set to Stay Shelley Wood April 05, 2019
News Daily News Volume Still an Important Surrogate for TAVR Quality, New Data Suggest Todd Neale April 03, 2019
Presentation SIF 2019 My Prediction on TAVR in Low Risk Patients Presenter: Kendra J. Grubb March 30, 2019
News Daily News Survival Better With Early AVR for Severe Asymptomatic Aortic Stenosis, Says Retrospective Study L.A. McKeown March 29, 2019
News Daily News CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers Michael O'Riordan March 27, 2019
News Conference News ACC 2019 SAFARI Surprise: No Survival or Bleeding Advantage With Radial Over Femoral Access in STEMI Michael O'Riordan March 18, 2019
News Opinion Editor's Corner ACC 2019 Live From New Orleans: Days 2 and 3 at ACC 2019 Shelley Wood March 18, 2019
News Conference News ACC 2019 TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients Yael L. Maxwell March 17, 2019
News Conference News ACC 2019 Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery Michael O'Riordan March 17, 2019
Presentation ACC 2019 Primary Results From the Evolut Low Risk Trial Presenter: Michael J. Reardon March 17, 2019